For Immediate Release ROWLETT REGIONAL CANCER CENTER OPENS ITS DOORS TO DALLAS Dallas' Newest Cancer Center to Provide Local Patients Access to Today's Most Innovative Medical and Radiation Oncology Services ROWLETT, TX. - In efforts to provide local patients access to today's most advanced cancer care, Dallas' newest freestanding cancer center - Rowlett Regional Cancer Center - has announced that it has opened its doors to the community. The cancer center is located in the new Lake Pointe Medical Arts Building at 7501 Lakeview Parkway (SH-66), Suite 120, in Rowlett, TX. Dr. R Steven Bradfield will provide state-of-the-art radiation oncology services and Dr. G.H. Kashef will provide advanced medical oncology, hematology and other infusion services. The physicians collaborated and partnered with Manhattan Beach, CA-based Vantage Oncology, Inc. to assist in providing advanced information technologies and management expertise. This allows Drs. Bradfield and Kashef and their highly skilled clinical team to efficiently provide optimal patient care in a comfortable environment. In 2005, Dr. Bradfield envisioned a new comprehensive cancer center conveniently located for the 400,000 population residing in the Rowlett, Rockwall, Heath, Forney, Wylie, Sachse, Garland and other surrounding communities. Construction of the new 10,500 square foot state of the art cancer facility was completed in February 2008. Understanding that cancer treatment can take an emotional and physical toll on patients and their families, an experienced cancer treatment team was carefully selected as was an environment that was conducive to healing. The center was designed with the ultimate goal of patient safety and comfort. For example, each chemotherapy chair has a flat screen TV with wireless headphones so patients may watch their favorite television programs or movies while receiving chemotherapy or other infusion treatments. Rowlett Regional Cancer Center operates the Varian 21ix one of the most advanced linear accelerators available today. This enables the center to offer the most sophisticated forms of radiation therapy. These include Intensity Modulated Radiation Therapy (IMRT) as well as Image-Guided Radiation Therapy (IGRT) capabilities. IMRT and IGRT are two significant innovations in radiation therapy technology currently used to treat cancer. By combining daily imaging to confirm the size and location of the tumor before each treatment session, radiation oncologists are able to more precisely treat tumors throughout the body. As a result, patients are exposed to less radiation to normal healthy tissue thus facilitating the preservation of these tissues and minimizing the potential side effects and complications. "The new technologies such as IMRT and IGRT aid the physician in delivering higher doses of radiation therapy to tumors with fewer complications and less immediate and long-term side effects," added Dr. Bradfield. "With a coordinated multidisciplinary approach of chemotherapy and radiation therapy available under one roof, patients will have the best chance for achieving optimal treatment results with the added convenience of a local center." "The joint venture between Rowlett Regional Cancer Center and Vantage Oncology, Inc. will provide patients in the Northeast Dallas Region with access to state-of-the-art diagnostic, medical and radiation oncology services" said Michael T. Fiore, CEO of Vantage Oncology, Inc. We are fortunate to have partnered with Drs. Bradfield and Kashef who possess the dedication and clinical capabilities to compassionately educate and effectively treat patients." CONTACT: Trace Longo Longo Communications (949) 364-2821 Karen Mattocks Vantage Oncology (310) 335-4074 http://www.vantageoncology.com